Interestingly, we obtained similar result and conclusion when we used the Kaplan–Meier survival analysis, revealing that CD93 was a high-risk factor in BLCA (p = 0.013), KIRP (p = 0.002), LGG (p < 0.001), LUSC (p = 0.023), OV (p = 0.013), STAD (p = 0.002), and UVM (p = 0.004) (Figures 2B–H). Here, CD93 is linked to bladder transitional cell carcinoma.